We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
(-6.1%)
Cap. Flow
-$1.56B
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$352M |
| 2 |
Kroger
KR
|
+$279M |
| 3 |
AT&T
T
|
+$235M |
| 4 |
Intel
INTC
|
+$217M |
| 5 |
Edwards Lifesciences
EW
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$461M |
| 2 |
Merck
MRK
|
+$459M |
| 3 |
Coca-Cola
KO
|
+$295M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$283M |
| 5 |
TSMC
TSM
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.08% |
| 2 | Technology | 16.14% |
| 3 | Healthcare | 15.45% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Consumer Staples | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Latham Group
SWIM
$673M
| $337K | ﹤0.01% |
94,200
+48,700
| +107% | +$278K |
|
2877
NVE Corp
NVEC
$564M
| $336K | ﹤0.01% |
7,199
-10,106
| -58% | -$503K |
|
2878
Molson Coors Class B
TAP
$7.97B
| $336K | ﹤0.01% |
+7,001
| New | +$380K |
|
2879
Epsilon Energy
EPSN
$165M
| $335K | ﹤0.01% |
52,982
-67,053
| -56% | -$436K |
|
2880
Braze
BRZE
$2.83B
| $334K | ﹤0.01% |
+9,600
| New | +$405K |
|
2881
ChargePoint
CHPT
$138M
| $333K | ﹤0.01% |
1,127
+474
| +73% | +$144K |
|
|
BRKL
2882
DELISTED
Brookline Bancorp
BRKL
| $332K | ﹤0.01% |
+28,500
| New | +$377K |
|
2883
Telecom Argentina
TEO
$5.86B
| $332K | ﹤0.01% |
82,745
-55,640
| -40% | -$244K |
|
2884
A.O. Smith
AOS
$8.82B
| $330K | ﹤0.01% |
6,800
-45,110
| -87% | -$2.59M |
|
2885
Anterix
ATEX
$1.78B
| $328K | ﹤0.01% |
+9,151
| New | +$380K |
|
2886
Kopin
KOPN
$654M
| $328K | ﹤0.01% |
312,920
-177,821
| -36% | -$248K |
|
2887
POSCO
PKX
$15.5B
| $327K | ﹤0.01% |
8,921
-81,174
| -90% | -$3.62M |
|
|
ENFN
2888
DELISTED
Enfusion, Inc.
ENFN
| $327K | ﹤0.01% |
+26,517
| New | +$323K |
|
2889
Harrow
HROW
$1.47B
| $326K | ﹤0.01% |
26,999
+1,030
| +4% | +$8.36K |
|
2890
Extra Space Storage
EXR
$32.2B
| $325K | ﹤0.01% |
1,890
-14,684
| -89% | -$2.78M |
|
|
TBI
2891
Trueblue
TBI
$235M
| $325K | ﹤0.01% |
+17,040
| New | +$345K |
|
|
CFB
2892
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $325K | ﹤0.01% |
24,929
-70,078
| -74% | -$950K |
|
2893
Invesco CurrencyShares Japanese Yen Trust
FXY
$426M
| $324K | ﹤0.01% |
5,013
-4,481
| -47% | -$303K |
|
2894
Radiant Logistics
RLGT
$411M
| $324K | ﹤0.01% |
56,960
+31,863
| +127% | +$224K |
|
|
ALPN
2895
DELISTED
Alpine Immune Sciences Inc
ALPN
| $323K | ﹤0.01% |
45,077
+9,147
| +25% | +$75.4K |
|
|
BRSP
2896
BrightSpire Capital
BRSP
$683M
| $321K | ﹤0.01% |
50,905
-51,119
| -50% | -$422K |
|
|
EEX
2897
DELISTED
Emerald Holding
EEX
| $320K | ﹤0.01% |
94,597
+13,070
| +16% | +$47.2K |
|
|
GLS.WS
2898
CALL
DELISTED
Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
GLS.WS
| $320K | ﹤0.01% |
296,304
-5,000
| -2% | -$394 |
|
|
AEVAW
2899
CALL
DELISTED
Aeva Technologies Warrants
AEVAW
| $319K | ﹤0.01% |
170,000
| – | – |
|
|
AIV
2900
Aimco
AIV
$375M
| $318K | ﹤0.01% |
+43,500
| New | +$357K |
|
Similar funds
Marshall Wace's Q3 2022 Portfolio in Review
As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.
- Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
- Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
- Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
- Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
- Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
- Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
- Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.
Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.